Besides, by restraining MAD2L1, miR-200c-5p can inhibit HCC cells proliferation, migration and invasion (Li Y. et al., 2017), suggesting that MAD2L1 can be used in HCC patients prognostic evaluation and targeted therapy. This evidence concerns the gene MAD2L1 and hepatocellular carcinoma.